Rohrdorf/Achenmühle and Arnhem – Medline International BV, one of Europe’s leading manufacturers and suppliers of medical devices, and Germany-headquartered Medi-Globe Group, today announced that Medline has entered into a definitive agreement to acquire 100% of the shares of ASID BONZ GmbH from the Medi-Globe group.
ASID BONZ is a leading supplier for clinics and hospitals in Germany and offers high-quality products for surgery, anesthesia, ward care and urology. ASID BONZ was founded in 1811 and is known worldwide for developing the first anesthetic ether. In 2021, ASID BONZ achieved a turnover of more than 30 million euros and supplied more than 1,100 hospitals in Germany.
With similar business models and first-class customer service, the two companies form an excellent strategic fit. Going forward, Medline will also make the ASID BONZ brand available outside of Germany for its large European customer base. In Germany, ASID BONZ sales representatives will have access to select Medline products to further expand their partnership with customers.
“We are delighted to expand our product offering and work with this award-winning company, known for its exceptional customer focus,” said Tripp Amdur, Group President, Medline Europe. “Medline is a relative newcomer to the field of urology and anesthesia. With this acquisition, we are expanding our presence in these regions. ASID BONZ’s people, products and services have long been recognized and trusted, and this combination will allow us to better meet the needs of our healthcare customers and become an even more valuable partner. »
Martin Lehner, CEO of Medi-Globe Group, adds: “ASID BONZ is known for its relentless commitment to its customers, providing high quality medical products that are used to treat patients every day. We are confident that ASID BONZ will have significant growth opportunities under Medline ownership in the future. The sale of ASID BONZ reinforces the Medi-Globe Group’s focus on its core business – the development and commercialization of innovative single-use products for minimally invasive diagnostic and therapeutic procedures.
Both parties expect the acquisition to close in May 2022, subject to antitrust approval and other closing conditions.
With 27,000 employees worldwide and a particularly strong presence in North America and Europe, Medline is a global healthcare leader that manufactures and markets high quality medical and surgical products. Medline prides itself on meeting the needs of its customers and improving health care around the world every day. Medline Europe was founded in 2011. Since then the company has grown rapidly, operating offices, production and distribution centers across the continent and now serving customers in 27 European countries. Learn more about Medline at medline.eu/de.
About Medi-Globe Group
The Medi-Globe Group is an innovative, growing and internationally oriented medical technology group in the fields of urology, gastroenterology and pulmonology. The head office is located in Achenmühle in the Chiemgau, Bavaria, approximately 70 kilometers south of Munich. Around 670 employees work for the Medi-Globe Group, founded in 1990, in Germany, France, the Czech Republic, China, Brazil, the Netherlands and Austria. Customers include university clinics, specialist clinics, specialized medical institutions and specialists in gastroenterology, urology and pulmonology in approximately 120 countries around the world. The managing directors are Martin Lehner (CEO), Christian Klein (COO), Dr. Nikolaus König (CFO) and Marc Jablonowski (CTIO). More information on: medi-globe.com